Resources search

A trade agreement’s impact on access to generic drugs

SHAFFER, Ellen R
BRENNER, Joseph E
August 2009

Expand view

This article reports on a study which examined the availability of certain drugs in Guatemala and found that the Central America Free Trade Agreement (CAFTA) intellectual property rules reduced access to some generic drugs already on the market and delayed the new entry of other generics. It found that some drugs protected from competition in Guatemala will become open for generic competition in the United States before generic versions will be legally available in Guatemala

Thailand's experience with compulsory licensing

MSF CAMPAIGN FOR ACCESS TO ESSENTIAL MEDICINES
2009

Expand view

In this recording Dr Suwit Wibulpolprasert of the Thai Ministry of Public Health talks about Thailand's experience when it issued compulsory licenses for two antiretroviral medicines in order to be able to treat more patients. Despite being put on a 'trade black list' by the US Government, the move was a success in public health terms, enabling the Thai Government to purchase more medicines and dramatically increase the availability of treatment for people living with AIDS

Globalization, TRIPS and access to pharmaceuticals

WORLD HEALTH ORGANIZATION (WHO)
March 2001

Expand view

This leaflet looks at the impact on the health sector of global trade and the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). It lists the articles of the agreement that have the greatest relevance to essential medicines and to the pharmaceutical industry

E-bulletin

Source e-bulletin on Disability and Inclusion

Subscribe to updates